Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer

Correction to: British Journal of Cancer (2004) 90, 2312–2316. doi:10.1038/sj.bjc.6601814

Due to an error, the second author's name was omitted from the above paper. The correct author listing is shown below:

V Michalaki, M Odontiadis, K Syrigos, P Charles and J Waxman

Also, in the same paper, part of the labelling in Figures 1 and 2 is incorrect. The correct figures are reproduced below:

Figure 1.

Disease-specific survival in patients with localised prostate cancer, stratified into groups above or below the cutoff IL-6 level of 2.1 pg ml⁻¹.

Figure 2.

Disease-specific survival in patients with localised prostate cancer, stratified into groups above or below the cutoff TNF-α level of 1.9 pg ml⁻¹.